SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas

Daniel Compagno, Carole Merle, Aurélie Morin et al. · 2007

Read SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas by Daniel Compagno, Carole Merle, Aurélie Morin et al. (2007) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0001006.txt.

Description

Daniel Compagno, Carole Merle, Aurelie Morin and colleagues silenced a hormone receptor to slow resistant prostate cancer, in PLOS ONE in 2007. Prostate tumors first need male hormones to grow, and hormone blocking treatment shrinks them. In time, most return in a castration resistant form with a poor outlook, yet they often keep a working androgen receptor.

The team used small interfering RNA, delivered in living animals, to silence that receptor. Blocking the receptor directly tests whether resistant tumors still depend on it. If they do, the receptor stays a drug target even late in disease. The in vivo step moves the idea beyond cell dishes.

Catalog record

CREATORDaniel Compagno, Carole Merle, Aurélie Morin et al.
YEAR2007
COLLECTIONPAPERS
FORMATTXT
FILE SIZE48 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0001006

Browse the full library · About the Tower of Babel